AtriCure, Inc. (ATRC)
ATRC Stock Price Chart
Explore AtriCure, Inc. interactive price chart. Choose custom timeframes to analyze ATRC price movements and trends.
ATRC Company Profile
Discover essential business fundamentals and corporate details for AtriCure, Inc. (ATRC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
5 Aug 2005
Employees
1.30K
Website
https://www.atricure.comCEO
Michael H. Carrel
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
ATRC Financial Timeline
Browse a chronological timeline of AtriCure, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 10 Feb 2026
Upcoming earnings on 4 Nov 2025
EPS estimate is -$0.11.
Earnings released on 29 Jul 2025
EPS came in at -$0.02 surpassing the estimated -$0.15 by +86.67%, while revenue for the quarter reached $136.14M , beating expectations by +4.65%.
Earnings released on 29 Apr 2025
EPS came in at -$0.14 surpassing the estimated -$0.25 by +44.00%, while revenue for the quarter reached $123.62M , missing expectations by -5.34%.
Earnings released on 12 Feb 2025
EPS came in at -$0.08 surpassing the estimated -$0.23 by +65.22%, while revenue for the quarter reached $124.28M , beating expectations by +2.00%.
Earnings released on 29 Oct 2024
EPS came in at -$0.17 surpassing the estimated -$0.20 by +15.00%, while revenue for the quarter reached $115.91M , missing expectations by -3.29%.
Earnings released on 30 Jul 2024
EPS came in at -$0.17 falling short of the estimated -$0.15 by -13.33%, while revenue for the quarter reached $116.27M , beating expectations by +0.08%.
Earnings released on 1 May 2024
EPS came in at -$0.25 falling short of the estimated -$0.21 by -19.05%, while revenue for the quarter reached $108.85M , beating expectations by +1.83%.
Earnings released on 15 Feb 2024
EPS came in at -$0.21 surpassing the estimated -$0.22 by +4.55%, while revenue for the quarter reached $106.54M , beating expectations by +2.76%.
Earnings released on 1 Nov 2023
EPS came in at -$0.20 surpassing the estimated -$0.30 by +33.33%, while revenue for the quarter reached $98.29M , beating expectations by +1.61%.
Earnings released on 25 Jul 2023
EPS came in at -$0.12 surpassing the estimated -$0.27 by +55.56%, while revenue for the quarter reached $100.92M , beating expectations by +4.70%.
Earnings released on 2 May 2023
EPS came in at -$0.23 surpassing the estimated -$0.34 by +32.35%, while revenue for the quarter reached $93.49M , beating expectations by +6.81%.
Earnings released on 21 Feb 2023
EPS came in at -$0.09 surpassing the estimated -$0.18 by +50.00%, while revenue for the quarter reached $88.03M , beating expectations by +0.28%.
Earnings released on 1 Nov 2022
EPS came in at -$0.27 falling short of the estimated -$0.25 by -8.00%, while revenue for the quarter reached $83.25M , beating expectations by +1.78%.
Earnings released on 2 Aug 2022
EPS came in at -$0.32 falling short of the estimated -$0.30 by -6.67%, while revenue for the quarter reached $84.53M , beating expectations by +6.19%.
Earnings released on 3 May 2022
EPS came in at -$0.33 falling short of the estimated -$0.27 by -22.22%, while revenue for the quarter reached $74.58M , beating expectations by +4.79%.
Earnings released on 15 Feb 2022
EPS came in at -$0.30 falling short of the estimated -$0.26 by -15.38%, while revenue for the quarter reached $73.22M , beating expectations by +0.77%.
Earnings released on 3 Nov 2021
EPS came in at $2.11 surpassing the estimated -$0.32 by +759.37%, while revenue for the quarter reached $70.46M , beating expectations by +2.59%.
Earnings released on 4 Aug 2021
EPS came in at -$0.36 falling short of the estimated -$0.33 by -9.09%, while revenue for the quarter reached $71.38M , beating expectations by +16.88%.
Earnings released on 27 Apr 2021
EPS came in at -$0.38 surpassing the estimated -$0.41 by +7.32%, while revenue for the quarter reached $59.28M , beating expectations by +5.73%.
Earnings released on 23 Feb 2021
EPS came in at -$0.42 falling short of the estimated -$0.29 by -44.83%, while revenue for the quarter reached $57.73M .
Earnings released on 5 Nov 2020
EPS came in at -$0.11 surpassing the estimated -$0.34 by +67.65%, while revenue for the quarter reached $54.76M , missing expectations by -67.65%.
ATRC Stock Performance
Access detailed ATRC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.